178 related articles for article (PubMed ID: 6100607)
1. Biochemical monitoring of vasoactive peptides during angiotensin converting enzyme inhibition.
Giese J; Rasmussen S; Nielsen MD; Ibsen H
J Hypertens Suppl; 1983 Oct; 1(1):31-6. PubMed ID: 6100607
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive peptides and hypertension: role of angiotensin converting enzyme.
Johnston CI; Iansek R; Millar JA; McGrath BP; Matthews PG
Aust N Z J Med; 1981; 11(Suppl 1):59-63. PubMed ID: 6266379
[TBL] [Abstract][Full Text] [Related]
3. Converting enzyme activity in regulation of blood pressure and kidney function. A review.
Piryova B; Girchev R
Cor Vasa; 1984; 26(6):401-7. PubMed ID: 6098419
[No Abstract] [Full Text] [Related]
4. Hormonal changes with long-term converting-enzyme inhibition by captopril in essential hypertension.
Matthews PG; McGrath BP; Johnston CI
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():135s-138s. PubMed ID: 232017
[TBL] [Abstract][Full Text] [Related]
5. Converting enzyme inhibition in mild and moderate essential hypertension. I. Acute effects on blood pressure, the renin-angiotensin system and blood bradykinin after a single dose of captopril.
Rasmussen S; Leth A; Ibsen H; Damkjaer Nielsen M; Nielsen F; Giese J
Acta Med Scand; 1985; 218(5):435-42. PubMed ID: 3004113
[TBL] [Abstract][Full Text] [Related]
6. Hormonal responses to angiotensin blockade. Comparison between receptor antagonism and converting enzyme inhibition.
Johnston CI; Millar JA; Casley DJ; McGrath BP; Matthews PG
Circ Res; 1980 Jun; 46(6 Pt 2):I128-34. PubMed ID: 6247084
[No Abstract] [Full Text] [Related]
7. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
[TBL] [Abstract][Full Text] [Related]
8. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
Erman A; Boner G; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
[TBL] [Abstract][Full Text] [Related]
9. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
[TBL] [Abstract][Full Text] [Related]
10. The renin-angiotensin system during converting enzyme inhibition with captopril in patients with severe treatment-resistant hypertension.
Rasmussen S; Damkjaer Nielsen M; Ibsen H; Leth A; Giese J
Eur J Clin Invest; 1984 Feb; 14(1):30-6. PubMed ID: 6321195
[TBL] [Abstract][Full Text] [Related]
11. [Changes in angiotensinogen and des-angiotensin I-angiotensinogen in man and rat upon inhibition of converting enzyme].
Clauser E; Genain C; Bouhnik J; Corvol P; Ménard J
Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():157-61. PubMed ID: 6287956
[TBL] [Abstract][Full Text] [Related]
12. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
[TBL] [Abstract][Full Text] [Related]
13. Effects of converting enzyme inhibitors on renin-angiotensin system in normal rats.
Komori T; Takada T; Funae Y; Yamamoto K
Osaka City Med J; 1984 Jun; 30(1):17-30. PubMed ID: 6096787
[No Abstract] [Full Text] [Related]
14. A paradoxical increase in circulating ACE (angiotensin converting enzyme) activity after long-term administration of alacepril (ACE inhibitor).
Nishida S; Matsuki M; Sumitomo S; Kawai Y; Yoneda M
Horm Metab Res; 1997 Mar; 29(3):153-4. PubMed ID: 9137988
[No Abstract] [Full Text] [Related]
15. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension.
Johnston CI; Millar JA; McGrath BP; Matthews PG
Lancet; 1979 Sep; 2(8141):493-6. PubMed ID: 90216
[TBL] [Abstract][Full Text] [Related]
17. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
Chan PS; Ronsberg MA; Cervoni P
Fed Proc; 1984 Apr; 43(5):1346-50. PubMed ID: 6200364
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H
J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790
[TBL] [Abstract][Full Text] [Related]
19. Captopril versus enalapril: a comparison of 24 h humoral and hypotensive effects.
Cottone S; Grasso L; D'Ignoto G; Contorno A; Ziletti T; Carapelle E; Carone MB; Fulantelli MA; Cerasola G
Boll Soc Ital Biol Sper; 1987 Sep; 63(9):803-10. PubMed ID: 2833914
[No Abstract] [Full Text] [Related]
20. Efficacy of an oral angiotensin-converting enzyme inhibitor (captopril) in severe hypertension.
Zweifler AJ; Julius S; Nicholls MG
Arch Intern Med; 1981 Jun; 141(7):907-10. PubMed ID: 6263204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
